Lipid metabolism disorder. Serum cholesterol abnormal. ICD-10-CM E78.9 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 642 Inborn and other disorders of metabolism. Convert E78.9 to ICD-9-CM. Code History.
This is the American ICD-10-CM version of E78.9 - other international versions of ICD-10 E78.9 may differ. All neoplasms, whether functionally active or not, are classified in Chapter 2.
An inherited metabolic disorder that affects the metabolism of the lipids. Representative examples include gaucher disease, tay-sachs disease, and niemann-pick disease Condition in which there is a deviation or interruption in the processing of lipids in the body: synthesis, absorption, transport, storage, and utilization
E75. 6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E75.
The term dyslipidemia includes disorders of lipoprotein metabolism that lead to atherosclerosis. These abnormalities arise from genetic and secondary factors and are caused by excessive entry of lipoproteins into the bloodstream or an impairment in their removal, or both.
Code E78. 5 is the diagnosis code used for Hyperlipidemia, Unspecified, a disorder of lipoprotein metabolism other lipidemias. It is a condition with excess lipids in the blood.
ICD-10 code Z13. 220 for Encounter for screening for lipoid disorders is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Lipid metabolism involves the synthesis of the structural and functional lipids (such as phospholipids, glycolipids, sphingolipids, cholesterol, prostaglandins, etc.) that are characteristic of individual tissues and the degradation of lipids to satisfy the metabolic needs of the body (e.g., energy production).
Disorders that affect lipid metabolism may be caused by defects in the structural proteins of lipoprotein particles, in the cell receptors that recognize the various types of lipoproteins, or in the enzymes that break down fats.
ICD-10 code Z79. 899 for Other long term (current) drug therapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
The medical community recognizes lipid testing as appropriate for evaluating atherosclerotic cardiovascular disease. Conditions in which lipid testing may be indicated include: Assessment of patients with atherosclerotic cardiovascular disease. Evaluation of primary dyslipidemia.
The USPSTF strongly recommends screening men aged 35 and older for lipid disorders. The USPSTF strongly recommends screening women aged 45 and older for lipid disorders if they are at increased risk for coronary heart disease.
0, V81. 1 and V81. 2 are appropriately added to the list of covered diagnosis codes for lipid tests 80061, 82465, 83718 and 84478 under the cardiovascular screening benefit (section 1861(xx)).
272.9 is a legacy non-billable code used to specify a medical diagnosis of unspecified disorder of lipoid metabolism. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.